British Journal of Anaesthesia 1995; 75: 369–377 Malignant hyperthermia and compartment syndrome
نویسندگان
چکیده
Sir,—We were interested to read the report by O’Donnell and colleagues [1] of a patient with compartment syndrome occurring as a complication of malignant hyperthermia (MH). We recently managed a similar case. A 29-yr-old, previously healthy man presented for repair of a fractured tibial plateau. After induction of anaesthesia with propofol, midazolam and fentanyl, he was allowed to breathe isoflurane and 66 % nitrous oxide in oxygen. After 1.5 h he developed stridor which persisted despite attempts to manipulate the laryngeal mask airway. He was then given suxamethonium which resulted in the rapid onset of masseter and generalized muscle spasm. His temperature, measured nasally, increased rapidly to 40.3 C, arterial PCO2 reached 12.1 kPa and he developed a metabolic acidosis with a base deficit of 12.3 mmol litre 1. Serum potassium was 6.8 mmol litre 1 and creatinine kinase increased to greater than 190 000. Despite the severity of this fulminant attack of MH, the patient made a rapid response to dantrolene (total dose 5.5 mg kg 1). Within a few hours his metabolic derangement was corrected and his trachea was extubated on the following morning. Over the next 12 h he developed marked swelling of his right forearm, right calf and foot. This was associated with restricted movement, pain exacerbated by passive extension and decreased sensation to light touch. A diagnosis of compartment syndrome was made and he underwent fasciotomies to the relevant muscle compartments under general anaesthesia using propofol, fentanyl and atracurium. This and subsequent anaesthetics for wound closure were uncomplicated and the patient made a full recovery with no loss of function in either limb. With greater awareness among anaesthetists and the availability of dantrolene, patients with fulminant MH are much more likely to survive than previously [2]. Such patients are at risk of developing compartment syndrome and we emphasize the importance of clinical signs in the early diagnosis of this potentially serious complication of MH. When indicated, fasciotomy should be performed and we suggest that the risk of anaesthesia after recovery from fulminant MH is small, and not sufficient to justify avoiding surgery. A. P. H. STEELE M. M. IMRIE A. M. RUTHERFORD W. N. BRADLEY St Peter’s Hospital Chertsey Surrey
منابع مشابه
Upper limb compartment syndromes: a complication of malignant hyperthermia in a patient with ill-defined myopathy.
We report a case of compartment syndrome complicating malignant hyperthermia (MH) in a 12-yr-old girl with a history of myopathy and multiple skeletal deformities; she underwent bilateral Achilles tendon surgery. Marked oedema of both forearms became evident in the immediate postoperative period and resolved after conservative treatment. Compartment syndrome is a rare complication of MH. Early ...
متن کاملPorcine malignant hyperthermia. I: Metabolic and physiological changes.
Porcine malignant hyperthermia was studied in seven Pietrain pigs under standardized experimental conditions. In five animals malignant hyperthermia was triggered with suxamethonium and halothane, but in two pigs suxamethonium alone was used. Characteristic metabolic and physiological changes were found and these are discussed with regard to a possible mechanism to explain the malignant nature ...
متن کاملMalignant hyperthermia syndrome in an anxious patient.
A 30-yr-old patient with fulminant ulcerative colitis was anaesthetized on three occasions, for colectomy and rectal stump removal. The first anaesthesia, with droperidol and fentanyl and pancuronium neuromuscular block, was uneventful. Addition of suxamethonium on the second occasion and use of the original drugs plus nitrous oxide for the third anaesthesia produced symptoms of MH, which was c...
متن کاملAnaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy.
Central core disease and malignant hyperthermia (MH) are both associated with mutations in the RYR1 gene. We report the anaesthetic management of one such patient presenting for coronary artery bypass grafting. Her medication included aspirin 75 mg, atorvastatin 20 mg, isosorbide mononitrate 60 mg, atenolol 25 mg and glyceryl trinitrite sublingual spray as required. The use of aprotinin, statin...
متن کاملEuropean Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
It is 30 yr since the British Journal of Anaesthesia published the first consensus protocol for the laboratory diagnosis of malignant hyperthermia susceptibility from the European Malignant Hyperthermia Group. This has subsequently been used in more than 10 000 individuals worldwide to inform use of anaesthetic drugs in these patients with increased risk of developing malignant hyperthermia dur...
متن کامل